Ruoyu Huang Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2024	PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme.
1/2020	Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
1/2020	Long-term efficacy of surgical resection with or without adjuvant therapy for treatment of secondary glioblastoma in adults.
7/2019	Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA-218.
3/2018	A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruoyu Huang Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 01/2017
17	Glioma (Gliomas) 07/2023 - 01/2017
5	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 03/2018
3	Pain (Aches) 01/2024 - 01/2020
3	Trigeminal Neuralgia (Tic Douloureux) 01/2024 - 01/2020
2	Chronic Pain 01/2024 - 01/2020
2	Neuralgia (Stump Neuralgia) 01/2023 - 10/2019
1	Plasmacytoma 01/2024
1	Bronchopneumonia 12/2023
1	Brain Edema (Cerebral Edema) 12/2023
1	Hemorrhage 12/2023
1	Necrosis 12/2023
1	Poisoning 12/2023
1	Facial Pain (Myofacial Pain) 01/2021
1	Carcinogenesis 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Hyperalgesia 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2019

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2018
4	Biomarkers (Surrogate Marker)IBA 07/2020 - 01/2018
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 10/2019
3	Long Noncoding RNAIBA 01/2024 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2018
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 07/2019
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2017
2	EnzymesIBA 12/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2018
2	palmatineIBA 01/2021 - 01/2020
2	LigandsIBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 07/2019 - 01/2017
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2024
1	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 12/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2023
1	propylene dichlorideIBA 12/2023
1	Capsules (Microcapsules)IBA 12/2023
1	SolventsIBA 12/2023
1	Hormones (Hormone)IBA 07/2023
1	OxysterolsIBA 07/2023
1	CholesterolIBA 07/2023
1	Membrane LipidsIBA 07/2023
1	SteroidsIBA 07/2023
1	Purinergic P2X4 ReceptorsIBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	AldehydesIBA 12/2021
1	Aldehyde DehydrogenaseIBA 12/2021
1	Sermorelin (Sermorelin Acetate)FDA Link 03/2021
1	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2021
1	Galectins (Galectin)IBA 01/2021
1	Purinergic P2X7 ReceptorsIBA 01/2021
1	Extracellular Matrix ProteinsIBA 12/2020
1	fibulinIBA 12/2020
1	Epidermal Growth Factor (EGF)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 07/2020
1	ElementsIBA 07/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	MethyltransferasesIBA 12/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2019
1	Temozolomide (Temodar)FDA LinkGeneric 12/2019
1	epidermal growth factor receptor VIIIIBA 12/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2019
1	dihydromyricetinIBA 10/2019
1	SurvivinIBA 07/2019
1	Adenosine DeaminaseIBA 01/2018
1	DCMP Deaminase (Deoxycytidylate Deaminase)IBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	SolutionsIBA 01/2017
1	AntibodiesIBA 01/2017

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
2	Immunotherapy 12/2020 - 01/2017
2	Chemoradiotherapy 01/2020 - 12/2019
1	Radiotherapy 01/2021